IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — MEDP

Balance Sheet

(in billions USD)
MetricQ2 2026Q1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021
Cash & Equivalents0.500.650.290.050.440.660.510.410.100.040.050.030.040.080.400.340.33
Accounts Receivable0.440.390.370.380.300.310.300.280.290.280.260.250.230.220.190.160.16
Total Current Assets1.051.140.740.520.821.030.870.740.450.380.370.340.330.360.640.550.53
Property, Plant & Equipment0.160.140.130.140.130.120.120.120.110.110.110.100.100.100.090.090.08
Goodwill0.660.660.660.660.660.660.660.660.660.660.660.660.660.660.660.660.66
Intangible Assets0.000.000.000.000.000.000.000.000.000.010.010.010.010.010.010.010.01
Total Non-current Assets*1.010.991.021.051.081.051.051.051.041.031.030.990.990.990.940.920.92
Total Assets2.062.131.751.571.902.081.921.801.491.411.401.331.321.341.581.471.45
Accounts Payable0.040.030.030.040.060.030.030.020.030.030.040.030.030.030.030.020.02
Short-term Debt----------------0.000.060.120.140.25--------
Total Current Liabilities1.441.351.281.221.121.040.990.960.850.850.880.820.880.580.520.470.45
Total Non-current Liabilities*0.190.190.180.180.180.160.160.170.170.160.170.160.150.160.160.150.15
Total Liabilities1.621.531.461.401.301.201.161.121.021.021.050.981.030.740.680.620.59
Retained Earnings(0.51)(0.34)(0.60)(0.70)(0.27)0.07(0.03)(0.12)(0.30)(0.37)(0.41)(0.38)(0.45)(0.12)0.180.140.16
Total Stockholder Equity0.430.600.290.170.590.880.760.670.470.390.350.350.280.610.900.850.86

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Total Revenue707.33706.60708.45659.90603.31558.57536.59533.32528.10511.04498.40492.50460.87434.07394.10383.74351.21330.95308.55295.57
Selling, General & Admin48.1047.9244.9248.0846.6657.9045.4349.2241.4544.0842.5141.4139.4038.0333.4035.4233.2229.3727.6628.05
Operating Income146.82141.50153.27141.81126.34113.52125.38112.27105.15104.0787.3284.9178.3986.2076.4377.8360.2464.2054.8653.71
Pretax Income151.66147.59156.83142.84124.54118.17133.88118.78110.48112.7890.7183.2075.7486.0373.6581.8962.0065.3255.9254.74
Tax Provision30.3023.7221.7031.7034.283.5816.8622.3522.1310.1912.4112.6514.6813.144.9715.8712.644.015.896.16
Net Income121.36123.87135.13111.1490.26114.60117.0296.4388.35102.5978.3070.5561.0772.8968.6766.0349.3661.3150.0348.57
Basic EPS4.314.354.763.953.163.773.783.112.853.322.552.302.002.352.172.131.521.751.391.35
Diluted EPS4.254.284.653.863.103.673.673.012.753.202.462.221.932.272.082.051.461.691.321.29

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow162.01151.79192.65246.21148.53125.84190.67149.07116.40152.68156.40114.3982.5280.08136.68108.4996.6246.2670.8972.35
Capital Expenditures23.916.814.5410.716.119.997.6410.5412.875.509.998.708.459.519.247.1811.209.269.126.64
Free Cash Flow*138.10144.97188.12235.50142.41115.84183.02138.54103.53147.18146.41105.6874.0770.56127.44101.3185.4237.0061.7865.71
Investing Cash Flow(23.88)(6.75)(4.47)(10.66)(6.02)(9.99)(7.56)(10.49)(12.79)2.53(8.00)(8.66)(8.47)(9.50)(9.22)(7.19)(11.13)(11.21)(9.12)(6.60)
Financing Cash Flow(288.34)12.6722.733.41(540.56)(345.97)(168.61)6.270.677.661.52(49.27)(82.21)(52.68)(131.12)(109.11)(123.46)(412.08)2.43(5.21)

* Derived from reported values